dual antiplatelet therapy

https://www.aafp.org/afp/2017/1001/od1 Prolonged Dual Antiplatelet Therapy After MI Reduces Major Adverse Cardiac Events | AFP In patients who are stable one year post-MI, prolonged use of dual antiplatelet therapy may be an effective treatment to decrease major cardiac events and... major adverse cardiac events dual antiplatelet therapy https://www.miragenews.com/dual-antiplatelet-therapy-cut-benefits-post-cabg-1528221/ Dual Antiplatelet Therapy Cut Benefits Post-CABG | Mirage News Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and reduced clinically relevant dual antiplatelet therapy cut benefits post cabg https://www.aafp.org/pubs/afp/issues/2019/1015/p463.html Dual Antiplatelet Therapy for Patients with Cardiovascular Disease | AAFP Patients with established cardiovascular disease or risk factors (e.g., ischemic cerebrovascular disease, peripheral arterial disease, high risk of... dual antiplatelet therapy for patients cardiovascular disease aafp https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.762391/full Frontiers | Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon The drug-coated balloon (DCB) is an emerging percutaneous coronary intervention device with theoretical advantages and promising results. Recent clinical obs... dual antiplatelet therapy frontiers duration https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1533674/full Frontiers | New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke... Background and purposeThe objective of this study is to systematically review the efficacy and safety of cilostazol-based dual antiplatelet therapy (DAPT) in... dual antiplatelet therapy new options frontiers cilostazol https://www.biospace.com/re-deem-dabigatran-added-to-dual-antiplatelet-therapy-resulted-in-acceptable-bleeding-rates-post-mi RE-DEEM: Dabigatran Added to Dual Antiplatelet Therapy Resulted in Acceptable Bleeding Rates... dual antiplatelet therapy https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/08/24/00/08/stopdapt-3 Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium... Dharam J. Kumbhani, MD, SM, FACC dual antiplatelet therapy https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2021/05/05/18/45/Dual-Antiplatelet-Therapy-Versus Dual Antiplatelet Therapy vs. Aspirin in Stroke or TIA - American College of Cardiology Mollie McDermott, MD, MS dual antiplatelet therapy https://www.aafp.org/pubs/afp/issues/2019/0915/p378.html Dual Antiplatelet Therapy for High-Risk TIA and Minor Stroke: BMJ Rapid Recommendation | AAFP Based on a recent randomized controlled trial followed by a systematic review, the BMJ and MAGIC group concluded that dual antiplatelet therapy use for a... dual antiplatelet therapy https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2021/08/26/01/42/STOPDAPT-2-ACS Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium... Dharam J. Kumbhani, MD, SM, FACC dual antiplatelet therapy https://pmc.ncbi.nlm.nih.gov/articles/PMC10889184/ Dual Antiplatelet Therapy for the Acute Management and Long-term Secondary Prevention of Ischemic... To improve the efficacy over antiplatelet monotherapy, dual antiplatelet therapy (DAPT) has been increasingly adopted in the management of non-cardioembolic... dual antiplatelet therapy https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.954704/full Frontiers | Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients... Background Optimal duration of dual antiplatelet therapy (DAPT) in patients with diabetes mellitus (DM) who have undergone drug-eluting stent (DES) implantat... dual antiplatelet therapy drug eluting stent

Robuta